Intron A (interferon alfa-2b)
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for Intron A (interferon alfa-2b), covering 2014-01-20 to 2021-05-27. Get the full timeline:
Most recent: Clinical Trial Update: Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery [Phase 3]